Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TER vs MRNA✓SelectedUSD · MRNATER vs MRNA performance historyLatest closeAs of-9.96%11/20
Stock and ETF performance explorer

TER vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+122.4%
MRNA return
+153.9%
Excess return
-31.5%
Maximum drawdown
-58.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.0%-2.2%-7.8%-9.9%
7D-17.9%-12.7%-5.2%-17.4%
30D-40.7%-20.7%-20.1%-40.1%
3M-46.5%+46.3%-92.8%-47.4%
6M-40.5%+305.2%-345.7%-50.6%
YTD+5.9%+561.2%-555.3%-24.2%
1Y+31.6%+772.1%-740.5%-13.1%
3Y+122.4%+147.0%-24.6%+74.3%
All+122.4%+153.9%-31.5%+74.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling